Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Hypofractionated radiotherapy for localized prostate cancer using three-dimensional conformal radiotherapy technique: 3 years toxicity analysis.

White R, Woolf D, Li S, Alonzi R, Osler P, Hoskin P, Hughes R.

Indian J Cancer. 2015 Oct-Dec;52(4):654-7. doi: 10.4103/0019-509X.178409.

2.

Hypofractionated Dose Escalated 3D Conformal Radiotherapy for Prostate Cancer: Outcomes from a Mono-Institutional Phase II Study.

Tramacere F, Arcangeli S, Pignatelli A, Castagna R, Portaluri M.

Anticancer Res. 2015 May;35(5):3049-54.

PMID:
25964594
3.

Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.

Viani GA, Viana BS, Martin JE, Rossi BT, Zuliani G, Stefano EJ.

Cancer. 2016 Jul 1;122(13):2004-11. doi: 10.1002/cncr.29983. Epub 2016 Mar 29.

4.

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.

Patel N, Faria S, Cury F, David M, Duclos M, Shenouda G, Ruo R, Souhami L.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):534-9. doi: 10.1016/j.ijrobp.2013.02.010. Epub 2013 Apr 15.

PMID:
23597418
5.

Hypofractionated radiotherapy for favorable risk prostate cancer.

Rene N, Faria S, Cury F, David M, Duclos M, Shenouda G, Souhami L.

Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):805-10. doi: 10.1016/j.ijrobp.2009.05.047.

PMID:
20510194
6.

Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.

Guckenberger M, Lawrenz I, Flentje M.

Strahlenther Onkol. 2014 Jan;190(1):48-53. doi: 10.1007/s00066-013-0443-x. Epub 2013 Nov 8.

PMID:
24196279
7.

Toxicity report of once weekly radiation therapy for low-risk prostate adenocarcinoma: preliminary results of a phase I/II trial.

Menkarios C, Vigneault É, Brochet N, Nguyen DH, Bahary JP, Jolicoeur M, Beauchemin MC, Villeneuve H, Van Nguyen T, Fortin B, Lambert C.

Radiat Oncol. 2011 Sep 9;6:112. doi: 10.1186/1748-717X-6-112.

8.
9.

A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer.

Lock M, Best L, Wong E, Bauman G, D'Souza D, Venkatesan V, Sexton T, Ahmad B, Izawa J, Rodrigues G.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1306-15. doi: 10.1016/j.ijrobp.2010.04.054. Epub 2010 Aug 12.

PMID:
20708855
10.

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9. doi: 10.1016/j.ijrobp.2007.11.044.

PMID:
18313526
11.

The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques.

Vranova J, Vinakurau S, Richter J, Starec M, Fiserova A, Rosina J.

Radiat Oncol. 2011 Jul 27;6:87. doi: 10.1186/1748-717X-6-87.

12.

A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma : a report on acute toxicity.

Norkus D, Miller A, Kurtinaitis J, Haverkamp U, Popov S, Prott FJ, Valuckas KP.

Strahlenther Onkol. 2009 Nov;185(11):715-21. doi: 10.1007/s00066-009-1982-z. Epub 2009 Nov 10.

PMID:
19899003
13.

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.

Kupelian PA, Reddy CA, Carlson TP, Altsman KA, Willoughby TR.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):904-12.

PMID:
12095556
14.

Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study.

Zilli T, Jorcano S, Rouzaud M, Dipasquale G, Nouet P, Toscas JI, Casanova N, Wang H, Escudé L, Mollà M, Linero D, Weber DC, Miralbell R.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):382-9. doi: 10.1016/j.ijrobp.2010.05.057. Epub 2010 Sep 29.

PMID:
20884129
15.

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma.

Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA.

Cancer. 1999 Jun 1;85(11):2460-8.

PMID:
10357419
16.

Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.

Aluwini S, Pos F, Schimmel E, van Lin E, Krol S, van der Toorn PP, de Jager H, Dirkx M, Alemayehu WG, Heijmen B, Incrocci L.

Lancet Oncol. 2015 Mar;16(3):274-83. doi: 10.1016/S1470-2045(14)70482-6. Epub 2015 Feb 3. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25656287
17.

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results.

Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J.

Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1099-105.

PMID:
17336216
18.

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment.

Viani GA, da Silva LB, da Silva BB, Crempe YB, Martins VS, Ferrari RJ, Pólo MC, Rossi BT, Suguikawa E, Zulliani GC, Stefano EJ.

Radiat Oncol. 2013 Apr 21;8:94. doi: 10.1186/1748-717X-8-94.

19.

Hypofractionated radiotherapy with or without IGRT in prostate cancer: preliminary report of acute toxicity.

Valeriani M, Monaco F, Osti MF, DE Sanctis V, Minniti G, Enrici RM.

Anticancer Res. 2011 Oct;31(10):3555-8.

PMID:
21965777
20.

Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity.

Soete G, Arcangeli S, De Meerleer G, Landoni V, Fonteyne V, Arcangeli G, De Neve W, Storme G.

Radiother Oncol. 2006 Jul;80(1):78-81. Epub 2006 Jul 7.

PMID:
16828910

Supplemental Content

Support Center